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Clinical diagnosis of lower urinary tract dysfunction (LUTD), such as bladder outlet obstruction (BOO) or
overactive bladder (OAB), is usually based on presenting symptoms. A biomarker for objective diagnosis
of these LUTDs is mandatory. Detrusor wall thickness (DWT) has been noted to be increased in men with
BOO and children with bladder-induced enuresis. Patients with OAB are also found to have thicker DWT
compared with controls. Although clinical studies using transabdominal or transvaginal ultrasound
examination have reported a thicker DWT in patients with BOO or OAB, the reported data are not
consistent and lack standardization. We believe that DWT is a promising biomarker for objective diag-
nosis of LUTD, but the examination technique, including sonoprobe frequency, route of scanning,
magniﬁcation, and landmarks of bladder wall measurement, need standardization before DWT can be
widely applied for clinical diagnosis of LUTD.
Copyright  2011, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
All rights reserved.1. The promise of bladder wall thickness as a biomarker
for overactive bladder diagnosis
Lower urinary tract dysfunction (LUTD) is highly prevalent in
men and women. Overactive bladder (OAB) is a syndrome based on
self-reported symptoms of urgency and frequency with or without
urgency urinary incontinence [1]. OAB might be because of detru-
sor overactivity (DO) or increased bladder sensation. Because
patients usually cannot differentiate the sensation of urgency from
the urge to void, confusion often exists between these two disease
entities [2]. Sometimes, patients with interstitial cystitis/painful
bladder syndrome (IC/PBS) also report symptoms similar to OAB. A
more objective way to diagnose and assess therapeutic outcomes in
patients with OAB or IC/PBS is needed.
Bladder outlet obstruction (BOO) is a commonly diagnosed
LUTD for men with lower urinary tract symptoms (LUTS). A high
proportion of men with BOO may also have OAB because of DO
[3,4]. Diagnosis of BOO can only be made based on invasive uro-
dynamic study, such as pressure ﬂow study or videourodynamic
study. A noninvasive method to diagnose BOO is mandatory for
more accurate treatment.hist Tzu Chi General Hospital,
el.: þ886 3 856 1825x2117;
ddhist Compassion Relief Tzu ChiBecause patients with OAB may have frequent detrusor
contractions during the storage phase, it is possible that sustained
isometric detrusor contractions could result in increased muscle
bulk and hence, increased detrusor wall thickness (DWT). It has
been hypothesized that DWT increases in patients with DO [5]. The
thickened bladder wall might decrease in response to anti-
muscarinic treatment, and measurement of DWT might therefore
be a useful biomarker for evaluation of disease progression and
effectiveness of treatment for OAB.
DWT has been noted to be increased in men with BOO and
children with bladder-induced enuresis [6,7]. In patients with OAB,
frequent detrusor contractions during bladder ﬁlling might result
in tetanic detrusor motion and cause hypertrophy of the detrusor
muscles. The detrusor is believed to increase in weight after long-
term increased workload because of BOO [8]. Therefore, measure-
ment of DWT has been proposed as a useful diagnostic parameter
or it could act as a possible biomarker to replace conventional
urodynamic pressure ﬂow study in patients with BOO and other
types of voiding dysfunction [8e10].
Related studies have not provided consistent ﬁndings. Blatt et al
[11] and Kuo et al [12] reported that DWT did not differ among
healthy controls, patients with BOO, patients with DO, and patients
with IBS. These results have challenged previous studies, which
showed that an increase in DWT was associated with an increasing
degree of BOO and that DWT had a predictive value in the diagnosis
of BOO. Thus, further conﬁrmation of the extent of the difference
in DWT between patients with OAB and control participants isFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Transvaginal ultrasound measurement of the detrusor wall thickness at the
bladder neck, anterior wall, posterior wall, and bladder base [16]. BN¼ bladder neck;
A¼ anterior wall; P¼ posterior wall; Base¼ bladder base.
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objective diagnostic biomarker to assess LUTD.
2. Transabdominal DWT measurement in healthy adults
and children
Bladder wall thickness (BWT) has been noted to increase in
patients with benign prostatic hyperplasia and BOO as well as in
spinal cord injury. The measurement techniques have varied
greatly with different sonographic probe frequencies and scanning
routes. The bladder wall contains the detrusor muscle wall,
mucosal layer, and perivesical fat tissue. If we use a low frequency
sonoprobe, these tissues might be involved in the thickness of
bladder wall. However, if the scanning frequency increases, we can
separate the detrusor wall from the other tissues. Therefore, the
true detrusor thickness might be delineated clearly.
Oelke et al [13] found a hyperbolic relationship between an
increasing volume and decreasing DWT, with no signiﬁcant
changes in the DWT with increasing bladder volumes beyond
250 mL. In 55 healthy adult volunteers between 15 years and
40 years of age, DWT was measured at the anterior bladder wall
with a 7.5-MHz ultrasound probe and with a full bladder. The DWT
decreased rapidly during the ﬁrst 250 mL of bladder ﬁlling but,
thereafter, remained almost stable until maximal bladder capacity.
No statistical differencewas found between the DWTat 250 mL and
at higher volumes. Men had a greater DWT thanwomen (1.4 mm vs.
1.2 mm, p< 0.001). The age and body mass index did not have
a signiﬁcant impact on DWT. It seems reasonable to expect that the
DWT decreases as the bladder volume increases, and therefore,
comparison of the DWT between subgroups requires correction for
bladder volumes less than 250 mL [13].
Muller et al [14] have standardized transabdominal ultrasound
(TAU) measurement of BWT in children and evaluated its reliability.
The thickness of the low echogenic layer of the ventral and dorsal
walls was 0.4e2.9 mm (median, 0.9) and 0.4e2.8 mm. (median,
1.1), respectively. The dorsal wall was slightly thicker than the
ventral wall. The intra- and interobserver variability of measure-
ments (standard deviation) was estimated to be 0.2 mm. for each
wall part.
We have also measured the DWT in three groups of controls
in different clinical studies using a high-resolution ultrasound probe
[12,15,16]. The mean DWT in the controls was only 1.13 0.30 mm
in one study, which compared DWT among controls, patients with
OAB, and patients with IC/PBS [12]. However, in another study using
an 8-MHz transabdominal sonographic probe (E8 model LOGIQ
P5/A5; GE Healthcare, Milwaukee, WI, USA), the DWT in the 28
controls was 0.844 0.294 mm at a bladder volume of 250 mL,
0.646 0.177 mm at bladder capacity and 0.800 0.243 mm with
a bladder capacity corrected to 250 mL [15].
In the third study, we measured the transvaginal ultrasound
(TVU) DWT in 28 control women using an 8-MHz transvaginal
sonographic probe (E8C model LOGIQ P5/A5). The DWT of an
emptied bladder was 4.73 0.97 mm at the anterior wall,
3.831.06 mm at the posterior wall, 4.671.12 mm at the bladder
base, and 9.10 2.11 mm at the bladder neck [16] (Fig. 1). Whenwe
measured the DWT of the same group of patients from the lower
abdomen using an 8-MHz transabdominal sonographic probe (8C
model LOGIQ P5/A5), the DWT was 0.926 0.287 mm at a bladder
volume of 250 mL, 0.739 0.232 mm at bladder capacity, and
0.925 0.257 mm with the bladder capacity corrected to 250 mL.
Putting these data together, it is clear that DWT changes with
bladder volume and varies greatly when measured through
different scanning routes. Therefore, it is necessary to standardize
the technique and scanning frequency in measurement of DWT
when comparing DWT between subgroups with different bladderdisorders or when performing a longitudinal study of DWT as
a biomarker for assessing OAB.3. Transabdominal and transvaginal DWT measurement
techniques
The differences in the values of DWT obtained in various
previous studies may have been caused by the use of different
ultrasound probes with different frequencies as well as by differ-
ences in the resolution of images. A review of previous reports
found that studies using a higher frequency probe (7.5 MHz)
reported a DWT of around 1e2 mm [8,9,11], whereas those using
a low frequency probe (2e5 MHz) reported a greater DWT of
around 4e5 mm [5,10,17,18]. In our previous studies, we used an 8-
MHz high frequency probe to measure the DWT either by TAU or
TVU [15,16]. Because the resolution power was able to differentiate
the detrusor wall from the posterior rectus fascia, the measured
DWT tended to be much less than would have been obtained using
a 2e5 MHz low frequency probe (Fig. 2). Although low intra- and
interobserver variability has been reported [14], careful identiﬁ-
cation of the true bladder wall and accurate placement of cursors to
measure the landmarks of DWT require experience.
When measuring DWT by TAU, the sonographic probe is placed
without pressure on the midline of the lower abdomen and scan-
ning is performed perpendicular to the bladder wall [12,15].
Increasing sonographic magniﬁcation is used to obtain a high-
resolution picture of the bladder wall. During measurement of the
detrusor wall, a careful examination is performed to identify the
posterior rectus fascia and distinguish it from the true bladder wall.
Using the zoom function, the layers of the bladder wall are
apparent. The perivesical tissue, mucosa, and submucosal tissue
appear hyperechogenic (bright) and the detrusor appears hypo-
echogenic (dark). The transducer is manipulated to obtain
maximum delineation and ensure the beam is perpendicular to the
wall. The bladder wall images are recorded and DWT measure-
ments are made at three different sites along the wall (Fig. 2). The
average of these three measurements is used as the DWT value at
that bladder volume.
When measuring DWT by TVU, all patients are allowed to void
freely, and the postvoid residual (PVR) is recorded, using TAU to
Fig. 2. Transabdominal sonography of the DWT. (A) The bladder wall should be traced laterally to distinguish it from the posterior rectus fascia (arrowheads) and true detrusor wall
(arrows). (B) The DWT is determined by measuring the upper margins of the two hyperechoic lines of the bladder wall at three different sites [15]. CF¼ catheter ﬁlling;
DWT¼ detrusor wall thickness; NF¼ natural ﬁlling.
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decubitus position, TVU is performed using an 8-MHz transvaginal
sonographic probe (E8C model LOGIQ P5/A5) for the DWT
measurement, including the DWT at the bladder neck, anterior
wall, posterior wall, and bladder base (Fig. 1).
Themeasurement of the DWT by TVU is more accurate than that
measured by TAU because the high-resolution, high-frequency
sonoprobe can delineate the detrusor wall from peritoneal fat and
perivesical fat tissue. However, if we do not increase songraphic
magniﬁcation, the perivesical fat or peritoneal fat might be
mistaken for the true detrusor wall, especially when a low
frequency probe is used. Khullar et al [5] found that a mean BWT
greater than 5 mm with TVU is a sensitive screening method for
diagnosing detrusor instability in symptomatic women without
outﬂow obstruction. The data are quite similar to that in our
previous study measuring DWT inwomenwith OAB [16]. However,
there were still small differences in the DWT between studies, most
likely because of lack of standardization in detecting landmarks of
the bladder wall (Table 1).4. Effect of bladder volume on DWT and corrected DWT
We believe the difference in the measured DWT in previous
studies is because of different frequencies for the ultrasound probe
and resolution of images. In addition, most previous studies used
a ﬁxed bladder volume of 200e300 mL to measure DWT [10,19,20].
This was based on the report of Oelke et al [8] showing a hyperbolic
relationship between increasing volume and decreasing DWT, with
no signiﬁcant difference in DWT at bladder volumes of 250 mL and
beyond. However, we thought the DWT should change as the
bladder volume increases. In addition, the volume infused into the
bladder might be increased because of the diuretic effect when
a patient is lying supine. Under this consideration, the bladder
volume should be measured by the voided volume plus PVR urine
volume.Table 1
The detrusor wall thickness in four sites of the bladder wall in symptom and
urodynamic subgroups [16]
Subgroup (n) Anterior wall
(mm)
Posterior wall
(mm)
Bladder base
(mm)
Bladder neck
(mm)
Control (28) 4.73 0.97 3.83 1.06 4.67 1.12 9.10 2.11
OAB-dry (28) 4.26 1.41 3.57 0.87 4.51 1.20 8.12 2.20
OAB-wet (25) 4.81 1.45 4.19 1.33 5.11 1.81 9.20 1.98
ANOVA (p) 0.307 0.170 0.327 0.161
ANOVA¼ analysis of variance; OAB¼ overactive bladder.In Fig. 3, we assumed the bladder to be a spherical container and
the measured DWT could, therefore, be corrected to a constant
volume (250 mL in this study) for comparison among patients with
different bladder volumes. Interestingly, we found the statistical
difference of a corrected DWT between patients with OAB and
controls remained the same as that of the measured DWT [12]. We
believed this volume correction method might be a better way of
measuring DWT in clinical application when assessing bladder
dysfunction.
In addition, the actual bladder volumemight be greater than the
infused volume because of diuresis when the patient is lying
supine. Under these considerations, the bladder volume should be
measured as the voided volume plus the PVR to minimize the
inaccuracy of sonographic measurement. Interestingly, we found
the true bladder capacity was 1.47 and 1.37 times that of the esti-
mated volume measured by TAU or a catheter-ﬁlling method [12].
Comparison of DWT at a ﬁxed bladder volume by catheter ﬁlling
might not be accurate. Based on this corrected method, we
measured the DWT in 57 participants without LUTS (controls),
including 20 men and 37 women, and found no signiﬁcant differ-
ence in the measured DWT or the corrected DWT (Table 2). The
measured DWT in the controls, patients with OAB-dry and patients
with OAB-wet decreased with a hyperbaric curve from the emptied
bladder to 250 mL, then decreased slowly to bladder capacity [15].
Therefore, 250 mL seems to be an optimal bladder volume in
measuring DWT without correction. DWT measured at bladder
volumes lower or higher than 250 mL should be corrected to
prevent a volume effect on the accuracy of the DWT (Fig. 4).
5. Clinical implication of DWT in children with voiding
dysfunction
Yeung et al [20] compared the bladder volume and wall thick-
ness index (BVWI, %) in healthy and enuretic children in correlation
with functional bladder capacities. They delineated the BWT and
capacity as follows: a BVWI less than 70 indicated a small capacity
bladder with a thick wall, a BVWI of 70e130 showed a normal
bladder capacity with a normal wall thickness, and a BVWI greater
than 130 revealed a large bladder capacity with a thinwall. Patients
with good responses to treatment had a normal BVWI, whereas
poor responses to treatment were signiﬁcantly associated with
pathological bladder conditions. BWT has also been used in the
diagnosis of dysfunctional voiding in children with recurrent
urinary tract infection. Yeung et al [21] further evaluated the role of
bladder variables measured by ultrasonography in assessing
bladder dysfunction in childrenwith urinary tract infections. A high
Fig. 3. The method for correcting the DWT to a bladder volume of 250 mL: (A) measurement of the bladder volume; (B) estimation of the DWT by the average of three
measurements at different sites; (C) correction of the measured DWT by the equation: T1¼ R2/ R1 T2, where T1 is the thickness of the detrusor wall at volume 1 mL, R1 is the
radius of bladder at volume 1 mL, T2 is the thickness of detrusor wall at a volume of 250 mL, and R2 is the radius of bladder at a volume of 250 mL [12]. DWT¼ detrusor wall
thickness.
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bladder rather than a normal or thin bladder in children, and 92% of
patients with a BVWI less than 70 had an OAB. They conﬁrmed the
BWT in children can provide useful predictive clues, which may be
helpful in differentiating treatment subtypes, guiding clinical
management, and minimizing the need for invasive urodynamic
studies in children.
Sreedhar et al [7] prospectively evaluated the role of ultrasound
measured bladder parameters for assessment of bladder dysfunc-
tion and posttreatment bladder functional changes and their
correlation with treatment outcome in children with primary
nocturnal enuresis. BVWI were calculated based on ultrasound
studies and classiﬁed as thick (less than 70), normal (70e130), or
thin (more than 130). The criteria for diagnosing urodynamic
patterns included normal, overactive, and underactive detrusor
activity. A total of 96% of patients with an index less than 70
exhibited bladder overactivity on ultrasound. All of the children
with a normal index had either a complete or good response to
treatment, whereas 62.5% of those with an index less than 70 did
not respond to treatment. They concluded that this ultrasoundTable 2
The DWT in control men and women [12]
Parameters Men
(n¼ 20)
Women
(n¼ 37)
Total
(n¼ 57)
Statistics
Age (yr) 54 15 49 16 51 16 All NS
Measured DWT (mm) 1.05 0.20 1.17 0.33 1.13 0.3
Bladder volume (mL) 364 183 361 188 362 185
Corrected DWT (mm) 1.15 0.24 1.27 0.39 1.23 0.35
DWT¼ detrusor wall thickness; NS¼ not signiﬁcant.protocol can provide useful predictive clues in differentiating
between various treatment subtypes.
6. DWT in BOO
OAB is a highly prevalent disorder, affecting 17% of the pop-
ulation and negatively impacting quality of life [22]. Bladder wall
hypertrophy and increased bladder weight has been found in
animal studies of partial BOO [23,24]. It has been speculated that
the detrusor contracts against increased bladder outlet resistance,
and muscle hypertrophy and collagen deposition develop [25].
Bladder wall hypertrophy has been correlated with detrusor func-
tion. Independent studies have shown that surgical treatment of
benign prostatic obstruction results in a signiﬁcant decrease of
bladder mass [26]. Preliminary data suggest the possibility that
medical treatment with alpha-adrenergic antagonists might also
produce a reduction in bladder wall hypertrophy [27]. Multiple
investigators have tried to develop an easier, ofﬁce-based, nonin-
vasive diagnostic tool for BOO using ultrasound measurement of
the DWT [9,10,13,17]. Previous study showed that measurement of
the DWT could detect BOO better than free uroﬂowmetry, PVR, or
prostatic volume [8]. An increased BWT and bladder wall mass
(BWM) were highly correlated with the degree of BOO. An ultra-
sonographically assessed DWT of 2.9 mm or greater has a high
predictive value for BOO and can replace pressure ﬂow study for the
diagnosis of BOO [9].
Oelke et al [6,8] found that the DWT increases depending on the
extent of BOO. Both constrictive and compressive BOO lead to an
increase in DWT. BOO is found in 95.5% of men with a DWT
S2 mm. They proposed a DWT cutoff value of >2.0 mm to predict
BOO in men. Kessler et al [9] suggested a DWT cutoff value of
Fig. 4. Nonlinear regression between DWT and bladder volume in (A) controls; (B) patients with OAB-dry; and (C) patients with OAB-wet either by catheter ﬁlling (CF) or natural
ﬁlling (NF) [16]. DWT¼ detrusor wall thickness; OAB¼ overactive bladder.
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sure ﬂow study. A BWT of more than 2.9 mm had a positive
predictive value of 100% and a sensitivity of 43% in the diagnosis of
BOO in men and could replace pressure ﬂow study. However,
because many cases of BOO still cannot be detected using the TAU
DWT technique, clinical application in screening for male BOO
remains limited (Fig. 5).
Hakenberg et al [17] measured the BWT with TAU in 172 men
with normal lower urinary tracts, 166 women with normal lower
urinary tracts, and 150 men with mild LUTS and clinically benign
prostatic enlargement (BPE). The overall mean BWT was 3.35 mm.
The mean BWT was 3.04 mm in healthy women, 3.33 mm inFig. 5. The measured DWT among unobstructed, equivocal, and obstructed patients.
Although the predictive value of BOO is good with a cutoff value of 2.9 mm for the
DWT, the sensitivity is only 43% [8]. BOO¼ bladder outlet obstruction; DWT¼ detrusor
wall thickness.healthy men, and 3.67 mm in men with LUTS and BPE. A small
increase in BWT with age is seen for both genders, and BWT tends
to be greater in men than women. Men with LUTS and BPE show
amoderate increase in BWT.Moreover, the resolution of ultrasound
and accurate identiﬁcation of the bladder wall varied greatly in
previous ultrasound studies of DWT. The differences in method-
ology used tomeasure the DWT resulted in awide variation of DWT
in patients with BOO, with values ranging from 2.0 mm to 5.0 mm
[8e10,17].
TAU measurement of BWT or DWT is widely used by most
urologists as a tool to assess the bladder condition in patients with
LUTS. However, most gynecologists prefer a transvaginal route.
Generally, there should be no difference between DWT and BWT.
However, TAU measures DWT at a larger bladder volume
[9,11,12,15], whereas TVU measures DWT with a nearly empty
bladder [5,16]. The bladder volume effect on DWT or BWT varies
greatly. The results of previous studies of DWT and BWT in patients
with BOO or DO also report discrepant results. The possible causes
of these discrepancies might include inconsistent bladder ﬁlling
conditions or differences in resolution of the ultrasound probe. In
fact, the difference between DWT and BWT may be that perivesical
tissue is involved in the measurement of BWT using a low
frequency sonoprobe, whereas DWT measured by a high frequency
probe can delineate the true detrusor wall. The bladder weight,
which measures the whole bladder mass, can overcome the prob-
lems between BWT and DWT and ﬁlling volume. However, the
major concern is still the accuracy of DWT measurement, which
needs clear standardization.
In addition tomeasuring DWT in BOO, ultrasoundmeasurement
of BWM has also been studied. Kojima et al [28] reported results of
the only study to compare ultrasound-estimated bladder width
(UEBW) with BOO. They found 94% of obstructed patients had an
UEBW greater than 35 g. In another study by Kojima et al [29],
BWM was measured by ultrasound in 33 obstructed men before
and after prostatectomy for BPE. Results indicated that the bladder
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controls and the BWM of the obstructed group decreased signiﬁ-
cantly from 52.9  22.6 g to 31.615.8 g (p < 0.05) after relief of
BOO.7. DWT in OAB and DO
TVU assessment of mean BWT has been found to be a sensitive
screening tool, which can detect detrusor instability inwomenwith
equivocal laboratory urodynamics. In women who have no
evidence of genuine stress urinary incontinence in laboratory
studies, a cutoff BWT of 6.0 mm is highly suggestive of detrusor
instability [18]. Serati et al [30] compared the ultrasound
measurement of BWT in women with different urodynamic diag-
noses to correlate BWT with different urodynamic ﬁndings of DO.
Urodynamics and BWT measurement by TVU were performed.
Patients were divided into four urodynamic subgroups, OAB-wet/
OAB-dry, urodynamic stress incontinence, mixed incontinence, and
normal urodynamics. They found that women with DO had a BWT
value signiﬁcantly higher (p< 0.0001) than the other patients. The
measured BWT was 5.221.17 mm in DO, 4.09 0.86 mm in uro-
dynamic stress incontinence, 4.731.27 mm in mixed inconti-
nence, and 4.191.14 mm in normal urodynamics. A cutoff of
6.5 mm for BWT had a positive predictive value of 100% for all DO.
Although the ultrasound BWT showed a highly signiﬁcant associ-
ation with DO, the data showed a high level of overlap and were
only reliable in women with DO with a BWT cutoff value greater
than 6.5 mm. They concluded that TVU-BWT cannot currently
replace urodynamic testing.
Kuo et al [31] recently compared the differences in DWT and
urine nerve growth factor (NGF) levels between patients with OAB
and controls to evaluate their suitability as biomarkers in OAB.
Eighty-one patients, including normal controls (n¼ 28), patients
with OAB-dry (n¼ 28), and patients with OAB-wet (n¼ 25) were
studied. Urine NGF and DWTmeasurements were performed at full
bladder and urge to void after natural ﬁlling or catheter ﬁlling
during pressure ﬂow study. DWT was measured by TAU. The total
bladder volume was calculated as the voided volume plus PVR.
These two parameters were compared among different symptom-
atic and urodynamic subgroups. Key results of this study docu-
mented that DWT decreased rapidly from an empty bladder to
a bladder volume of 250 mL and slowly to the maximal bladder
volume. DWT was not signiﬁcantly different among subgroups at
250 mL bladder volume. Although patients with OAB-wet had
a signiﬁcantly greater DWT at the maximal bladder volume, this
was not signiﬁcantly different from controls after correction of the
volume factor (Table 3). By contrast, urinary NGF levels were
signiﬁcantly increased in patients with OAB-wet and those with
urodynamic DO. However, elevated NGF levels in OAB-wet were
found only after natural ﬁlling and not after catheter ﬁlling.Table 3
TAU measured DWT at 250 mL, ﬁnal bladder capacity, and corrected DWT in
symptom subgroups in natural ﬁlling [15]
Subgroups DWT at 250 mL
(mm)
DWT at Bladder
capacity (mm)
Corrected DWT
(mm)
Control (n¼ 28) 0.926 0.287 0.739 0.232 0.925 0.257
OAB-dry (n¼ 28) 0.904 0.229 0.754 0.203 0.858 0.191
OAB-wet (n¼ 25) 1.048 0.318 0.976 0.379 1.04 0.326
ANOVA p¼ 0.144 Control vs. OAB-wet:
p¼ 0.008
OAB-dry vs. OAB-wet,
p¼ 0.007
OAB-wet vs.
OAB-dry, p¼ 0.048
ANOVA¼ analysis of variance; DWT¼ detrusor wall thickness; OAB¼ overactive
bladder; TAU¼ transabdominal ultrasound.Kuo et al [31] concluded that urinary NGF level in natural ﬁlling
urine samples is a better biomarker for assessment of OAB-wet than
DWT. Urine samples from catheter ﬁlling do not have detectably
high NGF levels. These ﬁndings need to be conﬁrmed by other
centers, but at this time it appears that urine biomarkers may be
superior to ultrasound measurement of the BWT as a biomarker for
OAB.
A recent observational study by Lekskulchai and Dietz [32]
found a statistically signiﬁcant correlation between DWT and DO,
which indicated that patients with DO have a thicker DWT
measured by translabial ultrasound. However, the low sensitivity
based on receiver operating characteristic analysis concluded that
DWT was not a useful diagnostic tool for DO, which contradicted
previously published studies using a cutoff value for DWT [5,18].
Our recent data in measurement of DWT in women with OAB-
dry, OAB-wet, and controls also provided further information that
measured DWT could be affected by the bladder volume [15].
Current data demonstrated the mean maximal bladder capacity of
healthy controls is signiﬁcantly greater than that of OAB patients.
Therefore, although patients with OAB-wet or DO had a signiﬁ-
cantly greater DWT at maximal volume than controls or patients
with IBS, no signiﬁcant difference was noted among all subgroups
after correcting the maximal volume to 250 mL. Although the DWT
at 250 mL and the corrected DWT showed no signiﬁcant difference
between patients with OAB and controls, a greater DWT measured
at bladder capacity (no matter how small the bladder capacity is)
can be considered a biomarker for DO in patients with OAB.
The results of these studies showed that DWT in women with
OAB-wet and DOwas not signiﬁcantly greater than that in OAB-dry,
controls, patients with IBS, or normal bladders at bladder volumes
of 250e300 mL. The DWT at maximal bladder volume, however,
was signiﬁcantly increased in OAB-wet or DO compared with other
subgroups. Because the maximal bladder volume in women with
OAB-wet or DO was signiﬁcantly smaller than other subgroups, the
signiﬁcantly increased DWT in patients with OAB-wet or DO at
maximal bladder volume is likely to result from a smaller bladder
capacity. Because the difference in DWT between OAB and controls,
or between DO and non-DO was too small, we suggest the reli-
ability and validity of the diagnosis of DO cannot be established by
a cutoff value of the DWT.
Findings have varied in published works onmeasurement of the
DWT or BWT in men and women as a tool to conﬁrm DO as well as
BOO. Most published data have conﬁrmed an increased DWT in
men with BOO compared with controls [9,11,12,16]. The BWT tends
to be greater in men than in women without LUTS. Men with LUTS
and BPE show a moderate increase in BWT. A small, signiﬁcant
increase of BWT is noted with age for both men and women [17].
We postulate that the pathophysiology of OAB is quite complicated,
especially in women. It has been demonstrated that the incidence
of male OAB caused by BOO is much higher than that in women
[20,26]. In other words, some men with OAB or DO might have
occult BOO, but most womenwith OAB or DO do not have BOO. This
could explain why the DWT of women with OAB was not signiﬁ-
cantly increased compared with controls. In addition, the exact
etiology of detrusor thickening in humans is still obscure.
Although there are statistically signiﬁcant differences in the
DWT at bladder capacity among OAB subgroups and controls, the
differences are small. We are not certain of the clinical signiﬁcance
of a 0.2e0.4 mm difference in thickness between controls and
patients with OAB or DO. Moreover, whether a 0.2e0.4 mm
difference in thickness can be reproduced with repeated
measurements by different investigators in different centers using
different machines needs further investigation. The DWTat bladder
capacity was increased inwomenwith OAB-wet or DO as measured
by TAU but not with the TVU approach.
Table 4
The DWT in controls, OAB-dry, OAB-wet, and IC patients [12]
Subgroups Men Women Statistics
Control
Age 54 15 (n¼ 20) 49 16 (n¼ 37) All NS
Measured DWT 1.05 0.20 1.17 0.33
Bladder volume 364 183 361 188
Corrected DWT 1.15 0.24 1.27 0.39
OAB-dry
Age 70 13 (n¼ 46)a 61 16 (n¼ 41)
Measured DWT 1.49 0.30a 1.30 0.40 p¼ 0.003
Bladder volume 306 153 319 206 p¼ 0.017
Corrected DWT 1.53 0.32a 1.33 0.43 p¼ 0.018
OAB-wet
Age 73 12 (n¼ 17)a 70 14 (n¼ 29) All NS
Measured DWT 1.70 0.45a 1.48 0.43a
Bladder volume 247 127 226 120a
Corrected DWT 1.60 0.51b 1.37 0.41
IC/PBS
Age 49 13 (n¼ 26)
Measured DWT 1.23 0.33
Bladder volume 242 134
Corrected DWT 1.19 0.29
DWT¼ detrusor wall thickness; IC/PBS¼ interstitial cystitis/painful bladder
syndrome; NS¼ not signiﬁcant; OAB¼ overactive bladder.
a p< 0.05 compared with the controls (p¼ 0.001).
b p< 0.05 compared with the IC/PBS group (p¼ 0.001).
Q.-S. Ke, H.-C. Kuo / Tzu Chi Medical Journal 23 (2011) 1e8 78. DWT in IC/PBS
IC/PBS is a bladder dysfunctionwith an undeﬁned pathogenesis.
This bladder disorder is usually diagnosed by subjective symptoms.
Patients with IC/PBS present with bladder pain and frequency.
Cystoscopic hydrodistention has been the gold standard procedure
to diagnose IC/PBS; however, not all patients with PBS have
cystoscopic ﬁndings. Therefore, searching for a biomarker to diag-
nose IC/PBS has been enthusiastically undertaken by urologists.
We examined the DWT in 26 patients with IC/PBS who visited
the urological clinic of a hospital [12]. Control participants were
patients who had nonurinary tract disorders and were free of LUTS.
Patients with IC/PBS were diagnosed by symptoms of bladder pain
and frequency, and their conditions had been proven previously by
cystoscopic hydrodistention under general anesthesia. DWT was
measured by 8-MHz transabdominal sonography with a full
bladder. The measured DWT and corrected DWT (1.23 0.33 mm
and 1.19 0.29 mm, respectively) did not show signiﬁcant differ-
ences between women with IC/PBS and female controls
(1.13 0.30 mm). However, the corrected DWT was signiﬁcantly
thinner in women with IC/PBS compared with that in women
with OAB-dry (1.40 0.36 mm) and OAB-wet (1.56 0.45 mm)
(p¼ 0.041 and 0.049, respectively) (Table 4).
This might be the ﬁrst observation of the DWT in IC/PBS patients.
Previously, we thought there could be ﬁbrosis in the bladder wall,
which induced a small functional bladder capacity in IC/PBS.
However, through ultrasound investigation, we found that the
bladderwalls inpatientswith IC/PBS tend to be thinner than those in
patients with OAB, and similar to those of controls, suggesting that
the main pathophysiology of the decreased capacity of an IC/PBS
bladder is inﬂammation of the bladder wall rather than ﬁbrosis. This
ﬁnding is also compatible with our clinical ﬁndings in IC/PBS blad-
ders during enterocystoplasty for patients with refractory IC/PBS.
9. Conclusions
Ultrasonographic measurement for LUTS is relatively new but
shows a promising future. Measurements of BWT, DWT, and UEBW
are potentially noninvasive clinical methods of assessing the lowerurinary tract. However, a lack of data in healthy asymptomatic
participants creates a disparity between studies and hampers the
use of ultrasound in routine practice. If methodological discrep-
ancies can be resolved, BWT, DWT, and UEBW will be valuable in
assessing LUTS. Studies clearly demonstrate a need for standard-
ized techniques and criteria. The International Consultation on
Incontinence-Research Society has recommended all future reports
should provide information about the frequency of ultrasound
probes, bladder ﬁlling volumes at measurement, if the BWT, DWT,
or UEBW was measured, enlargement factors for ultrasound
images, and one ultrasound image with marker positioning [33].
Only with these quality controls can ultrasonic measurements of
urinary bladders be considered suitable to quantify bladder wall
hypertrophy because of BOO, DO, or neurogenic bladder dysfunc-
tion in adult men, women, and children. Quantiﬁcation of bladder
wall hypertrophy seems to be useful for the assessment of diseases,
prediction of treatment outcomes, and longitudinal studies inves-
tigating disease development and progression.References
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